215 related articles for article (PubMed ID: 15247246)
1. O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits.
Wells L; Kreppel LK; Comer FI; Wadzinski BE; Hart GW
J Biol Chem; 2004 Sep; 279(37):38466-70. PubMed ID: 15247246
[TBL] [Abstract][Full Text] [Related]
2. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.
Wells L; Vosseller K; Hart GW
Science; 2001 Mar; 291(5512):2376-8. PubMed ID: 11269319
[TBL] [Abstract][Full Text] [Related]
4. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.
Gao Y; Wells L; Comer FI; Parker GJ; Hart GW
J Biol Chem; 2001 Mar; 276(13):9838-45. PubMed ID: 11148210
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.
Lefebvre T; Ferreira S; Dupont-Wallois L; Bussière T; Dupire MJ; Delacourte A; Michalski JC; Caillet-Boudin ML
Biochim Biophys Acta; 2003 Jan; 1619(2):167-76. PubMed ID: 12527113
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation.
Vocadlo DJ
Curr Opin Chem Biol; 2012 Dec; 16(5-6):488-97. PubMed ID: 23146438
[TBL] [Abstract][Full Text] [Related]
7. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol.
Vosseller K; Hansen KC; Chalkley RJ; Trinidad JC; Wells L; Hart GW; Burlingame AL
Proteomics; 2005 Feb; 5(2):388-98. PubMed ID: 15648052
[TBL] [Abstract][Full Text] [Related]
9. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.
Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA
J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853
[TBL] [Abstract][Full Text] [Related]
10. Detecting the "O-GlcNAc-ome"; detection, purification, and analysis of O-GlcNAc modified proteins.
Zachara NE
Methods Mol Biol; 2009; 534():251-79. PubMed ID: 19277546
[TBL] [Abstract][Full Text] [Related]
11. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
Whelan SA; Hart GW
Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
[TBL] [Abstract][Full Text] [Related]
12. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
13. Does O-GlcNAc play a role in neurodegenerative diseases?
Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the catalytic domain of O-linked N-acetylglucosaminyl transferase.
Lazarus BD; Roos MD; Hanover JA
J Biol Chem; 2005 Oct; 280(42):35537-44. PubMed ID: 16105839
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc modification of Sp3 and Sp4 transcription factors negatively regulates their transcriptional activities.
Ha C; Lim K
Biochem Biophys Res Commun; 2015 Nov; 467(2):341-7. PubMed ID: 26431879
[TBL] [Abstract][Full Text] [Related]
17. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
19. Functional significance of O-GlcNAc modification in regulating neuronal properties.
Hwang H; Rhim H
Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
[TBL] [Abstract][Full Text] [Related]
20. Global identification of O-GlcNAc-modified proteins.
Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
